BlackRock Fund Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
MAM
BA
O
EC
ACH
CAM
BC
BlackRock Fund Advisors's SNDX Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Syndax Pharmaceuticals (SNDX) stake by 16% in Q4 2016, buying an estimated $235K and bringing the position to 151,781 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #3222.
BlackRock Fund Advisors first reported a position in SNDX in Q2 2016 and has held it in 3 quarters since. The position peaked at $1.98M in Q3 2016. 57 funds tracked by Wall St. Rank hold SNDX as of Q4 2016.
- BlackRock Fund Advisors held 151,781 shares of Syndax Pharmaceuticals worth $1.09M as of Q4 2016.
- BlackRock Fund Advisors bought 21,418 Syndax Pharmaceuticals shares in Q4 2016, an estimated $235K.
- Syndax Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3222 holding.
- BlackRock Fund Advisors first reported a position in Syndax Pharmaceuticals in Q2 2016 and has held it in 3 quarters since.
- BlackRock Fund Advisors's Syndax Pharmaceuticals position peaked at $1.98M in Q3 2016.
- 57 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.